These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 11858616

  • 1. Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit.
    Tissié G, Sébastian C, Elena PP, Driot JY, Trinquand C.
    J Ocul Pharmacol Ther; 2002 Feb; 18(1):65-73. PubMed ID: 11858616
    [Abstract] [Full Text] [Related]

  • 2. A new long acting ophthalmic formulation of carteolol containing alginic acid.
    Séchoy O, Tissié G, Sébastian C, Maurin F, Driot JY, Trinquand C.
    Int J Pharm; 2000 Oct 10; 207(1-2):109-16. PubMed ID: 11036236
    [Abstract] [Full Text] [Related]

  • 3. Ocular distribution of carteolol after single and repeated ocular instillation in pigmented rabbits.
    Fujio N, Kusumoto N, Odomi M.
    Acta Ophthalmol (Copenh); 1994 Dec 10; 72(6):688-93. PubMed ID: 7747576
    [Abstract] [Full Text] [Related]

  • 4. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
    Demailly P, Allaire C, Trinquand C, Once-daily Carteolol Study Group.
    Br J Ophthalmol; 2001 Aug 10; 85(8):921-4. PubMed ID: 11466245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb 10; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of a long-acting ophthalmic formulation of carteolol containing alginic acid on the corneal epithelial barrier function and water retentive effect.
    Tokuda N, Inoue J, Yamazaki I, Ueno S, Fujisawa S.
    J Ocul Pharmacol Ther; 2012 Apr 10; 28(2):123-8. PubMed ID: 22217390
    [Abstract] [Full Text] [Related]

  • 9. Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride.
    El-Kamel A, Al-Dosari H, Al-Jenoobi F.
    Drug Deliv; 2006 Apr 10; 13(1):55-9. PubMed ID: 16401594
    [Abstract] [Full Text] [Related]

  • 10. Enhancement in Corneal Permeability of Dissolved Carteolol by Its Combination with Magnesium Hydroxide Nanoparticles.
    Nagai N, Yamaoka S, Fukuoka Y, Ishii M, Otake H, Kanai K, Okamoto N, Shimomura Y.
    Int J Mol Sci; 2018 Jan 17; 19(1):. PubMed ID: 29342127
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y, Nakamura K, Matsuki S, Uemura N, Muraguchi R, Nakagawa M, Nakano S, Nakatsuka K.
    J Clin Pharmacol; 2002 Sep 17; 42(9):1020-6. PubMed ID: 12211218
    [Abstract] [Full Text] [Related]

  • 12. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T, Carteolol Long-acting Formulation Study Group.
    Nippon Ganka Gakkai Zasshi; 2007 Jun 17; 111(6):463-72. PubMed ID: 17601060
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration].
    Kawase K, Yamamoto T, Muramatsu T, Ono J, Nakajima T, Matsuhisa A, Sugiura T, Migita M, Ishikawa Y.
    Nippon Ganka Gakkai Zasshi; 2010 Nov 17; 114(11):976-82. PubMed ID: 21141077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D, Charlin JF, Cohn H, Dascotte JC, George JL, Lesure P, Massin M, Massin G, Maurin JF, Renard JP.
    J Fr Ophtalmol; 1995 Nov 17; 18(10):589-96. PubMed ID: 8568162
    [Abstract] [Full Text] [Related]

  • 19. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM, Nguyen KP, Giacomini JC, Lee DA.
    J Ocul Pharmacol; 1991 Nov 17; 7(3):243-52. PubMed ID: 1686051
    [Abstract] [Full Text] [Related]

  • 20. [Intraocular penetration of 14C-Carteolol hydrochloride (beta-blocker) in the albino rabbits].
    Fujio N, Kitazawa T.
    Nippon Ganka Gakkai Zasshi; 1984 Feb 17; 88(2):236-41. PubMed ID: 6464847
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.